Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Pomyelo 1 mg Capsule
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$56.66 $44.19
Sidmex Inovia offers bulk export supply of Pomyelo 1 mg Capsule (Pomalidomide 1 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain...
Pomalidomide 1 mg
Active Pharmaceutical Ingredient
Pomyelo 1 mg Capsule
$56.66
$44.19
Sidmex Inovia offers bulk export supply of Pomyelo 1 mg Capsule (Pomalidomide 1 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Pomyelo 4 mg Capsule
Pomyelo 1 mg Capsule is an innovative treatment option specifically designed for individuals battling multiple myeloma, a complex form of blood cancer. As an immunomodulatory agent, Pomyelo works by enhancing the body’s immune response to help combat cancer cells more effectively. This medication is typically prescribed for patients who have undergone at least two previous treatment regimens, including lenalidomide and a proteasome inhibitor, to ensure the best possible outcomes. While Pomyelo can significantly contribute to cancer management, it is essential to be aware of potential side effects, which may include fatigue, increased risk of infection, and gastrointestinal disturbances. Regular monitoring by healthcare professionals is crucial to manage these risks effectively. Patients should also inform their doctors of any existing medical conditions or medications to avoid harmful interactions. With its targeted approach, Pomyelo 1 mg Capsule represents a valuable addition to the therapeutic arsenal against multiple myeloma, helping patients navigate their treatment journey with renewed hope. Always consult your healthcare provider for personalized advice and comprehensive information on this medication.
Active Pharmaceutical Ingredient
Uses
• Pomyelo 1 mg capsule is primarily utilized in the management of multiple myeloma, a malignancy that impacts plasma cells within the bone marrow. This condition can lead to various symptoms such as fatigue, weakness, and anemia. By targeting the underlying processes of the disease, Pomyelo 1 mg capsule aids in improving patient outcomes. It is often prescribed as part of a comprehensive treatment plan for individuals diagnosed with this type of blood cancer.
• In patients suffering from multiple myeloma, Pomyelo 1 mg capsule plays a critical role in alleviating symptoms associated with the disease. Many individuals experience debilitating fatigue and significant weight loss due to the cancer's effects on the body. By incorporating Pomyelo 1 mg capsule into their treatment regimen, patients may find relief from these distressing symptoms. This can lead to an enhanced quality of life as they navigate their treatment journey.
• Pomyelo 1 mg capsule is also indicated for use in combination with other therapies for the treatment of multiple myeloma. This multi-faceted approach helps to maximize the effectiveness of the overall treatment strategy. Healthcare providers often recommend Pomyelo 1 mg capsule to help manage disease progression and improve patient prognosis. Such collaborative treatment regimens are essential for optimizing care in individuals facing this challenging condition.
• Healthcare professionals may prescribe Pomyelo 1 mg capsule to patients with multiple myeloma who are experiencing a relapse or have not responded adequately to previous therapies. This medication can be crucial in re-establishing control over the disease. Its use can lead to a reduction in the severity of symptoms and improve overall patient health. For many, Pomyelo 1 mg capsule represents a vital option in the ongoing battle against multiple myeloma.
Benefits
Pomyelo shown to be effective in improving response rates in patients with relapsed or refractory multiple myeloma, particularly when used in combination with other treatments such as dexamethasone. Pomyelo 1 mg Capsule has been reported to have fewer side effects compared to other treatments for multiple myelomas, such as thalidomide and lenalidomide. Pomyelo 1 mg improve the quality of life for patients with multiple myeloma by reducing symptoms such as bone pain and fatigue. For patients with relapsed or refractory multiple myeloma, Pomyelo Capsule offers a new treatment option that may be more effective than previous treatments.
Side Effects
Like all medication, Pomyelo 1 mg Capsule may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Weakness
• Itching
• Fever
• Redness
• Blackish stool
• Bloody urine
• Muscle Spasm
• BodyacheSwelling of face, hands, legs, feet
• Bloating of abdomen
Common Side Effects
• Brain infection ( Memory loss, seizure, vision changes, Slurred speech, Lack of coordination)
• Liver Disease
• Severe abdominal pain, Yellowish eyes and skin
• Continuous Nausea and vomiting
• Breathing difficulty
• Severe Dizziness
How To Use
Pomyelo can be taken with or without food, but it is recommended to take it simultaneously each day for optimal results. Your doctor will determine dosage and frequency of use based on your specific condition which may change over time. You must follow your doctor's instructions and not change the dosage or frequency of intake without their guidance.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Pomyelo 1 Capsule. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Pomyelo. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Pomyelo 1 Capsule should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Pomyelo and report any unusual symptoms or changes in kidney function to their doctor. The dose of Pomyelo 1 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Pomyelo 1 mg. Pomyelo Capsule may pass into breast milk and harm the infant. If you are breastfeeding and taking Pomyelo, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Pomyelo should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Pomyelo 1 Capsule and report any unusual symptoms or changes in liver function to their doctor. The dose of Pomyelo 1 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Pomyelo Capsule may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Pomyelo 1 Capsule during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Pomyelo Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Pomyelo 1 mg.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.